LLY

805.71

-1.45%↓

UNH

556.95

-1.68%↓

JNJ

158.12

-1.16%↓

NVO

109.92

-1.81%↓

ABBV

200.71

-1.24%↓

LLY

805.71

-1.45%↓

UNH

556.95

-1.68%↓

JNJ

158.12

-1.16%↓

NVO

109.92

-1.81%↓

ABBV

200.71

-1.24%↓

LLY

805.71

-1.45%↓

UNH

556.95

-1.68%↓

JNJ

158.12

-1.16%↓

NVO

109.92

-1.81%↓

ABBV

200.71

-1.24%↓

LLY

805.71

-1.45%↓

UNH

556.95

-1.68%↓

JNJ

158.12

-1.16%↓

NVO

109.92

-1.81%↓

ABBV

200.71

-1.24%↓

LLY

805.71

-1.45%↓

UNH

556.95

-1.68%↓

JNJ

158.12

-1.16%↓

NVO

109.92

-1.81%↓

ABBV

200.71

-1.24%↓

Strona główna・Stock List・Takeda Pharmaceutical Co Ltd ADR

Takeda Pharmaceutical Co Ltd ADR

Open

Sector Healthcare

14.08 0.86

Buy Sell

Overview

Share price change

24h

Current

Min

13.92

Max

14.1

Recommendations
By TipRanks
Recommendations	Buy
12 Months Forecast	+6.02 upside

News Sentiment

By Acuity

50%

167 / 390 Ranking in Healthcare

Technical Score

By Trading Central

Confidence

Strong Bullish Evidence

13.86 / 14.15 Support & Resistance

Takeda Pharmaceutical Co Ltd ADR Chart

Past performance is not a reliable indicator of future results.

Related News

31 paź 2024, 07:27 UTC

Earnings

Takeda Pharmaceutical Posts Quarterly Net Profit, Raises Guidance -- Update

31 paź 2024, 06:44 UTC

Earnings

Takeda Pharmaceutical Posts Quarterly Net Profit, Raises Guidance

31 lip 2024, 07:19 UTC

Earnings

Takeda Pharmaceutical's First-Quarter Profit Rose on Higher Revenue -- Update

31 lip 2024, 06:29 UTC

Earnings

Takeda Pharmaceutical Reports Rise in First-Quarter Net Profit on Higher Revenue

17 cze 2024, 13:34 UTC

Major Market Movers

Ovid Therapeutics Shares Slide Premarket After Takeda's Soticlestat Setback

13 maj 2024, 11:26 UTC

Major Market Movers

AC Immunity Shares Soar on Exclusive License Deal with Takeda

9 maj 2024, 07:37 UTC

Earnings

Takeda Pharmaceutical Projects Lower Annual Profit After Quarterly Loss -- Update

9 maj 2024, 07:08 UTC

Earnings

Takeda Pharmaceutical Projects Lower Annual Profit After Quarterly Loss

1 lut 2024, 07:32 UTC

Earnings

Takeda Pharmaceutical's Third-Quarter Net Profit Dropped on Lower Margins -- Update

1 lut 2024, 06:55 UTC

Earnings

Takeda Pharmaceutical's Third-Quarter Net Profit Dropped on Lower Margins

31 sty 2024, 23:58 UTC

Major Market Movers

Protagonist Therapeutics Shares Rise 5.6% on Licensing Deal With Takeda

Peer Comparison

Price change

Takeda Pharmaceutical Co Ltd ADR Forecast

Price Target

By TipRanks

6.02% upside

12 Months Forecast

Average 14.8 USD 6.02%

High 14.8 USD

Low 14.8 USD

Based on 2 Wall Street analysts offering 12 month price targets forTakeda Pharmaceutical Co Ltd ADR - Dist in the last 3 months.

Rating Consensus

By TipRanks

Buy

2 ratings

Buy

Hold

Sell

Based on 2 analysts giving stock ratings to Takeda Pharmaceutical Co Ltd ADR - Dist in the past 3 months.

Technical Score

By Trading Central

13.86 / 14.15Support & Resistance

Recent bullish events outweigh bearish events.

Recent bearish events outweigh bullish events.

Sentiment

By Acuity

167 / 390 Ranking in Healthcare

Financials

Other stocks from the sector

LLY

Eli Lilly and Co.

805.71

↓-1.45%

UNH

UnitedHealth Group Inc

556.95

↓-1.68%

JNJ

Johnson and Johnson

158.12

↓-1.16%

NVO

Novo Nordisk A-S

109.92

↓-1.81%

ABBV

AbbVie Inc

200.71

↓-1.24%

Takeda Pharmaceutical Co Ltd ADR

Overview

Share price change

Recommendations

News Sentiment

Technical Score

Takeda Pharmaceutical Co Ltd ADR Chart

Related News

Peer Comparison

Takeda Pharmaceutical Co Ltd ADR Forecast

Price Target

Rating Consensus

Technical Score

Sentiment

Financials

Other stocks from the sector

Crucial information about Facebook accounts